Market revenue in 2023 | USD 51.0 thousand |
Market revenue in 2030 | USD 62.7 thousand |
Growth rate | 3% (CAGR from 2023 to 2030) |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD thousand |
Market segmentation | |
Key market players worldwide | Diasorin SpA, BioMerieux SA, Oxford Immunotec, Bio-Rad Laboratories Inc, Thermo Fisher Scientific Inc, T2 Biosystems Inc, IGeneX, Gold Standard Diagnostics, Zeus Scientific, Inc., Trinity Biotech PLC ADR |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to lyme disease testing market will help companies and investors design strategic landscapes.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico lyme disease testing market , including forecasts for subscribers. This country databook contains high-level insights into Mexico lyme disease testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account